# Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses

> **NCT03040323** · PHASE4 · TERMINATED · sponsor: **Indiana University** · enrollment: 83 (actual)

## Conditions studied

- Liver Biopsy

## Interventions

- **DRUG:** Lumason 60.7Mg Powder for Injection
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03040323
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-22
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-07-06
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** Insufficient patient recruitment. Data lost following departure of key personnel
- **Last updated:** 2019-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040323, "Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03040323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*